<DOC>
	<DOCNO>NCT02532738</DOCNO>
	<brief_summary>The investigator ' preliminary study indicate MSC effective therapy treat IBD . But standard treatment still lack effect stable IBD patient . This study explore efficacy standard strategy use MSC refractory IBD .</brief_summary>
	<brief_title>The Efficiency MSC Refractory Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Failure intolerance GC , immune inhibitor biological agent treatment CDAI 250450 Weight 40150 kg Normal renal function endoscopic image diagnosis CD small intestine , colon ileocolon Signed informed consent HIV active hepatitis patient ; Allergic CT contrast agent , cattle pig product ; Stricture perforation type CD ; Recieved permanent colostomy ; Used biological preparation 3 month Used prednisone &gt; 20 mg/day within 1 month ; Patients short bowel syndrome ; Need total parenteral nutrition ; Liver meritorious service abnormal ; Suffering malignant tumor last 5 year ; Combined bacterial viral enteritis ; Suffering intestinal typicality thicken live Patients tuberculosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>efficacy MSC</keyword>
	<keyword>refractory</keyword>
</DOC>